A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
LOXO-LNC-24001
Phase 1 other active
Quick answer
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors for Advanced or Metastatic Urothelial Carcinoma or Other Solid Tumors is a Phase 1 program (other) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Advanced or Metastatic Urothelial Carcinoma or Other Solid Tumors
- Phase
- Phase 1
- Modality
- other
- Status
- active